外科理论与实践

外科理论与实践 >

2021 , Vol. 26 >Issue 01: 38 - 40

DOI: https://doi.org/10.16139/j.1007-9610.2021.01.008

专家论坛

新辅助腹腔内联合全身化疗应用于胃癌腹膜转移的临床价值和实施要点

展开
  • 上海交通大学医学院附属瑞金医院外科,上海消化外科研究所,上海市胃肿瘤重点实验室,上海 200025

收稿日期: 2021-01-13

  网络出版日期: 2022-07-28

基金资助

国家自然科学基金项目(81772518);上海交通大学医学院多中心临床研究项目(DLY201602)

收起

Intraperitoneal combined with systemic neoadjuvant chemotherapy for treatment of peritoneal metastatic gastric cancer: clinical significance and key

Expand

Received date: 2021-01-13

  Online published: 2022-07-28

Fold

本文引用格式

严超, 燕敏, 朱正纲 . 新辅助腹腔内联合全身化疗应用于胃癌腹膜转移的临床价值和实施要点[J]. 外科理论与实践, 2021 , 26(01) : 38 -40 . DOI: 10.16139/j.1007-9610.2021.01.008

参考文献

[1] Yamaguchi T, Takashima A, Nagashima K, et al. Impact of preoperative chemotherapy as initial treatment for advanced gastric cancer with peritoneal metastasis limited to positive peritoneal lavage cytology(CY1) or localized peritoneal metastasis(P1a): a multi institutional retrospective study[J]. Gastric Cancer,2020-11-11.doi: 10.1007/s10120-020-01137-6.Epub ahead of print.PMID: 33179192.
[2] Fujitani K, Yang HK, Mizusawa J, et al. Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial[J]. Lancet Oncol, 2016, 17(3):309-318.
[3] Ishigami H, Fujiwara Y, Fukushima R, et al. Phase Ⅲ trial comparing intraperitoneal and intravenous paclitaxel plus S-1 versus cisplatin plus S-1 in patients with gastric cancer with peritoneal metastasis: PHOENIX-GC trial[J]. J Clin Oncol, 2018, 36(19):1922-1929.
[4] Gong Y, Wang P, Zhu Z, et al. Benefits of surgery after neoadjuvant intraperitoneal and systemic chemotherapy for gastric cancer patients with peritoneal metastasis: a meta-analysis[J]. J Surg Res, 2020, 245:234-243.
[5] 严超, 石红鹏, 刘瑩, 等. 胃癌腹膜转移的新辅助腹腔内联合全身化疗:初步研究[J]. 外科理论与实践, 2017, 22(1):32-39.
[6] Li C, Yan M, Chen J, et al. Surgical resection with hyperthermic intraperitoneal chemotherapy for gastric cancer patients with peritoneal dissemination[J]. J Surg Oncol, 2010, 102(5):361-365.
[7] 严超, 杨中印, 施敏, 等. 胃癌术后腹膜复发转移的腹腔镜诊断和腹腔内联合全身双向化疗的临床疗效[J]. 中华胃肠外科杂志, 2020, 23(5):492-498.
[8] Yang Z, Yan C, Yu Z, et al. Downregulation of CDH11 promotes metastasis and resistance to paclitaxel in gastric cancer cells[J]. J Cancer, 2021, 12(1):65-75.
[9] Yang Z, Li C, Liu W, et al. Complications and risk factors for complications of implanted subcutaneous ports for intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis[J]. Chin J Cancer Res, 2020, 32(4):497-507.
[10] Emoto S, Ishigami H, Hidemura A, et al. Complications and management of an implanted intraperitoneal access port system for intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis[J]. Jpn J Clin Oncol, 2012, 42(11):1013-1019.
Options
文章导航

/

〈 〉